WAYLAND, Mass.--(BUSINESS WIRE)--Candela Corporation (NASDAQ: CLZR) announced today that it has filed two requests for re-examination with the United States Patent & Trademark Office (“PTO”). One is for U.S. Patent Number 5,595,568 (the “ ’568 patent”) and the second is for U.S. Patent Number 5,735,844 (the “ ’844 patent”). Palomar Medical Technologies, Inc. (“Palomar”) is the exclusive licensee of the patents, which are the subject of Palomar’s patent infringement lawsuit brought against Candela on August 9, 2006 in the United States District Court for the District of Massachusetts. As Candela previously announced on November 18, 2008, the lawsuit is currently stayed.
